- Home
- ALLR vs IMTE Comparison
ALLR vs IMTE Comparison
Compare ALLR & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- IMTE
- Stock Information
- Founded
- ALLR 2004
- IMTE 2008
- Country
- ALLR United States
- IMTE Malaysia
- Employees
- ALLR N/A
- IMTE N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- ALLR Health Care
- IMTE Consumer Staples
- Exchange
- ALLR Nasdaq
- IMTE Nasdaq
- Market Cap
- ALLR 15.8M
- IMTE 3.3M
- IPO Year
- ALLR N/A
- IMTE N/A
- Fundamental
- Price
- ALLR $0.94
- IMTE $1.00
- Analyst Decision
- ALLR Strong Buy
- IMTE
- Analyst Count
- ALLR 1
- IMTE 0
- Target Price
- ALLR $9.00
- IMTE N/A
- AVG Volume (30 Days)
- ALLR 367.8K
- IMTE 30.5K
- Earning Date
- ALLR 08-15-2025
- IMTE 10-21-2025
- Dividend Yield
- ALLR N/A
- IMTE N/A
- EPS Growth
- ALLR N/A
- IMTE N/A
- EPS
- ALLR N/A
- IMTE N/A
- Revenue
- ALLR N/A
- IMTE $123,337.00
- Revenue This Year
- ALLR N/A
- IMTE N/A
- Revenue Next Year
- ALLR N/A
- IMTE N/A
- P/E Ratio
- ALLR N/A
- IMTE N/A
- Revenue Growth
- ALLR N/A
- IMTE 4.75
- 52 Week Low
- ALLR $0.61
- IMTE $0.51
- 52 Week High
- ALLR $6.00
- IMTE $3.17
- Technical
- Relative Strength Index (RSI)
- ALLR 47.03
- IMTE 46.33
- Support Level
- ALLR $0.85
- IMTE $0.92
- Resistance Level
- ALLR $1.01
- IMTE $1.02
- Average True Range (ATR)
- ALLR 0.05
- IMTE 0.06
- MACD
- ALLR -0.01
- IMTE 0.00
- Stochastic Oscillator
- ALLR 47.55
- IMTE 45.71
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.